Methods and compositions for use of tumor self-antigens in adoptive immunotherapy

摘要

The present disclosure provides methods and compositions for immunotherapy employing a modified T cell or NK cell comprising a receptor that binds to newly identified tumor antigens that can be administered to patients for disease (